Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Jan 31, 2024
Document Date
Jan 31, 2024
Form Description
Filing by person(s) reporting owned shares of common stock in a public company >5%
Filing Group
Other
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/